Peer review reports
From: Neuregulin-1 and ALS19 (ERBB4): at the crossroads of amyotrophic lateral sclerosis and cancer
Original Submission | ||
---|---|---|
2 Nov 2023 | Submitted | Original manuscript |
13 Nov 2023 | Reviewed | Reviewer Report |
28 Nov 2023 | Reviewed | Reviewer Report |
23 Dec 2023 | Author responded | Author comments - Jacob Adashek |
Resubmission - Version 2 | ||
23 Dec 2023 | Submitted | Manuscript version 2 |
2 Jan 2024 | Reviewed | Reviewer Report |
1 Feb 2024 | Author responded | Author comments - Jacob Adashek |
Resubmission - Version 3 | ||
1 Feb 2024 | Submitted | Manuscript version 3 |
Publishing | ||
12 Feb 2024 | Editorially accepted | |
19 Feb 2024 | Article published | 10.1186/s12916-024-03293-3 |